Process for using endogenous enkephalins and endorphins to inhib

Details Process for using endogenous enkephalins and endorphins to inhib Process for using endogenous enkephalins and endorphins to inhib

1987-10-01

1989-01-31

Phillips, Delbert R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530809, A61K 3702

Patent

active

048016144

ABSTRACT:
A process for the therapeutic treatment of cancer patients involving stimulation and promotion of the natural immune system (both T cell and NK cell activity) resisting and inhibiting tumorous growth (cancer) as well as resisting infections (viral, bacterial and fungal) by administering an effective dosage (e.g., 0.25 mg per kilogram of body weight to as low as about 10.sup.-14 mg/kg) of an endogenous endorphin (e.g., leucine-enkephalin and methionine-enkephalin).

REFERENCES:
patent: 4537878 (1985-08-01), Plotnikoff
Chem. Absts. vol. 96, (1982) 29203m.
Chem. Abstr. vol. 100, (1984) 173021u.
Internat'l Symposium on New Trends in human Immun & Cancer Immunotherapy (1980)48-55.

Affiliated with

Also associated with

Rating

Process for using endogenous enkephalins and endorphins to inhib does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for using endogenous enkephalins and endorphins to inhib, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for using endogenous enkephalins and endorphins to inhib will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-177727